FDA

News and Updates by the Food and Drugs Administration (FDA)

Arvinas and Pfizer Reveal Early Phase 1b Outcomes from TACTIVE-U Vepdegestrant-Abemaciclib Study at 2024 SABC Symposium

Arvinas, Inc., a biotechnology company in clinical development phases, together with Pfizer Inc., disclosed initial findings from the phase 1b segment of the TACTIVE-U study. This study explores the efficacy of the vepdegestrant and abemaciclib combination in patients with locally […]

Arvinas and Pfizer Reveal Early Phase 1b Outcomes from TACTIVE-U Vepdegestrant-Abemaciclib Study at 2024 SABC Symposium Read More »

NABL Extends Testing Lab Accreditation to 4 Years Amidst Comprehensive Overhaul

The National Accreditation Board for Testing and Calibration Laboratories (NABL) has unveiled a broad array of amendments designed to refine its accreditation procedures and alleviate challenges faced by testing laboratories. This overhaul includes notable updates to the accreditation timeline, evaluation

NABL Extends Testing Lab Accreditation to 4 Years Amidst Comprehensive Overhaul Read More »

Emphasizing the Role of Infrastructure and Technology in Delivering Patient-Focused Health Services

Universal Health Coverage (UHC) is designed to guarantee that everyone can access necessary healthcare services without financial strain. Achieving this goal means having a strong infrastructure and modern technology to provide patient-centered care. Every year on December 12, the global

Emphasizing the Role of Infrastructure and Technology in Delivering Patient-Focused Health Services Read More »

DCGI Set to Inaugurate AIPAC Event in Indore on December 12 to Empower MSMEs through Dissolution Science

The All India Pharmaceutical Association Consortium (AIPAC) has announced its inaugural programme, focused on enhancing the skills and scientific capabilities of pharmaceutical professionals, especially those from Micro, Small & Medium Enterprises (MSMEs). This initiative seeks to bolster knowledge and excellence

DCGI Set to Inaugurate AIPAC Event in Indore on December 12 to Empower MSMEs through Dissolution Science Read More »

Amgen Names Naveen Gullapalli as New Managing Director to Boost Indian Tech & Innovation

Amgen has declared the appointment of Naveen Gullapalli as its new managing director. He will oversee the operations at Amgen’s Technology and Innovation facility in Hyderabad, leveraging his broad expertise across pharmaceutical, finance, and tech sectors in guiding global operations

Amgen Names Naveen Gullapalli as New Managing Director to Boost Indian Tech & Innovation Read More »